Editorial Board

1.
Current Use of Diuretics in the Management of Hypertension

  • Aram V Chobanian ,Professor, School of Medicine, Boston University, Boston, Massachusetts USA, Aram V Chobanian, Professor, School of Medicine, Boston University, Boston, Massachusetts, USA e-mail: achob@bu.edu,
  • 2.
    Pheochromocytoma

  • Kakarla S Rao ,Chairman, KIMS Foundation Research Centre, Krishna Institute of Medical Sciences, Secunderabad, Telangana, India, Kakarla S Rao, Chairman, KIMS Foundation Research Centre, Krishna Institute of Medical Sciences Secunderabad, Telangana, India, Phone: +9104023563155 e-mail: subbaraokakarla25@gmail.com,
  • 3.
    Systolic and Diastolic Blood Pressure: Do We add or subtract to estimate the Blood Pressure Burden?

  • Tiny Nair ,PRS Hospital, Trivandrum, Kerala, India, Head, Department of Cardiology, P Ratnaswamy Hospital, Thiruvananthapuram, Kerala, India, PRS Hospital, Thiruvananthapuram, Kerala, India, PRS Hospital, Karamana, Trivandrum, Kerala, India, Professor and Head, Department of Cardiology,
  • 4.
    Renaissance of Chlorthalidone

  • Anil Pareek ,President, Medical Affairs and Clinical Research, IPCA Laboratories Limited, Mumbai, Maharashtra, India, Anil Pareek, President, Medical Affairs and Clinical Research, IPCA Laboratories Limited, Mumbai Maharashtra, India, e-mail: anil.pareek@ipca.com,

  • Mahesh Abhyankar ,General Manager, Medical Affairs and Clinical Research, IPCA Laboratories Limited, Mumbai, Maharashtra, India,

  • Suraj Ghag ,Manager, Medical Affairs and Clinical Research, IPCA Laboratories Limited, Mumbai, Maharashtra, India,
  • 5.
    From the Desk of Editor-in-Chief

  • 6.
    The Chlorthalidone Saga: How the US Medical Community was mislead in Past?

  • Franz H Messerli ,Professor, Department of Cardiology, Icahn School of Medicine at Mount Sinai, New York; University of Bern, Switzerland and Jagiellonian University, Kraków, Poland, Franz H Messerli, Professor, Department of Cardiology, Icahn School of Medicine at Mount Sinai, New York; University of Bern, Switzerland and Jagiellonian University Kraków, Poland, e-mail: messerli.f@gmail.com,
  • 7.
    Hypertension Capsule—Cardiological Society of India 2016: Swallow It!

  • Tiny Nair ,PRS Hospital, Trivandrum, Kerala, India, Head, Department of Cardiology, P Ratnaswamy Hospital, Thiruvananthapuram, Kerala, India, PRS Hospital, Thiruvananthapuram, Kerala, India, PRS Hospital, Karamana, Trivandrum, Kerala, India, Professor and Head, Department of Cardiology,
  • 8.
    Clinical Implications of Recent Therapeutic Trials in Hypertension: Insights from SPRINT and HOPE-3 Trials

  • Prakash Deedwania ,UCSF Program at Fresno, Fresno, California, USA, Chief of Cardiology Division VACCHCS/UMC, VACCHCS/UMC, UCSF Program at Fresno, Fresno, California, USA, Chief of Cardiology Division, UCSF School of Medicine, San Francisco, USA, Professor, Department of Medicine, VACCHCS/UCSF, Fresno, Ca; UCSF School of Medicine, San Francisco, USA, Chief Cardiology; Professor of Medicine, UCSF School of Medicine, San Francisco, California, USA,

  • Tushar Acharya ,Fellow, Advanced Cardiovascular Imaging Unit, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda Maryland, USA,
  • 9.
    Will the Systolic Blood Pressure Intervention Trial (SPRINT) change Treatment Targets in Hypertension?

  • Michael A Weber ,Professor, Department of Medicine, Division of Cardiovascular Medicine Downstate College of Medicine, State University of New York New York, United States, Michael AWeber, Professor, Department of Medicine, Division of Cardiovascular Medicine, Downstate College of Medicine, State University of New York, 450 Clarkson Avenue, Box 97, Brooklyn, New York 11203, United States, Phone: 714 815 7430, e-mail: michaelwebermd@cs.com,
  • 10.
    Autonomic Neuromodulation through Devices for Hypertension

  • Atul Pathak ,BLK Superspeciality Hospital, New Delhi, India, Clinical Associate and IDCCM Fellow, Critical Care Medicine,

  • Benjamin Honton ,Professor, Department of Cardiovascular Medicine, Hypertension and Heart Failure Unit, Health Innovation Lab, Clinique Pasteur Toulouse, France,

  • Olivier Fondard ,Professor, Department of Cardiovascular Medicine, Hypertension and Heart Failure Unit, Health Innovation Lab, Clinique Pasteur Toulouse, France,

  • Nicolas Dumonteil ,Professor, Department of Cardiovascular Medicine, Hypertension and Heart Failure Unit, Health Innovation Lab, Clinique Pasteur Toulouse, France,

  • Didier Tchetche ,Professor, Department of Cardiovascular Medicine, Hypertension and Heart Failure Unit, Health Innovation Lab, Clinique Pasteur Toulouse, France,

  • Jean Fajadet ,Professor, Department of Cardiovascular Medicine, Hypertension and Heart Failure Unit, Health Innovation Lab, Clinique Pasteur Toulouse, France,
  • 11.
    Heart Rate as a Marker of Cardiovascular Prognosis

  • Gino Seravalle ,Professor, Department of Cardiology, Institute Auxologico Italian, IRCCS San Luca Hospital, Milan, Italy,

  • Guido Grassi ,Professor, Department of Clinical and Preventive Medicine, Clinical Medicine, University Milano-Bicocca, Monza, Italy, Guido Grassi, Professor, Department of Clinical and Preventive Medicine, Clinical Medicine, University Milano-Bicocca, Monza, Italy, Phone: +390392333357, e-mail: guido.grassi@unimib.it,
  • © Jaypee Brothers Medical Publishers (P) LTD.